过氧化物酶体增殖物激活受体-γ激动剂对急性胰腺炎大鼠肺损伤的保护机制研究  被引量:4

Protection of PPAR-γ agonists on lung injury in rats with acute pancreatitis

在线阅读下载全文

作  者:陆贝[1] 于源泉[2] 殷俊杰[1] 蔡阳[1] 

机构地区:[1]杭州市第一人民医院肝胆外科,浙江杭州310006 [2]浙江大学医学院附属第二医院肝胆外科,浙江杭州310009

出  处:《中国现代医生》2017年第18期38-41,F0003,共5页China Modern Doctor

基  金:浙江省医药卫生科技计划项目(2014KYA172)

摘  要:目的探讨过氧化物酶体增殖物激活受体-γ激动剂对胰腺炎大鼠肺损伤的保护作用及调节机制。方法 72只大鼠随机分为假手术组、模型组和罗格列酮组,各组再分为术后6 h、12 h、24 h组。模型组采用两次腹腔注射L-精氨酸制备SAP模型,罗格列酮组术后30 min静脉注射10%罗格列酮6 mg/kg,假手术组腹腔注射等体积生理盐水。观察大鼠肺病理改变,测定肺TLR4、NF-κB、肺髓过氧化物酶活性、肺干/湿重比、血清TNF-α、IL-1β、IL-6含量。使用重复测量方差分析,SNK-q检验比较差异。结果 ROSI组大鼠肺组织病理损害较SAP组减轻;与SAP组比较,肺内NF-κB、TLR4蛋白下降(P<0.05),髓过氧化物酶活性及肺干/湿重比降低(P<0.05);ROSI组外周血IL-1β、IL-6、TNF-α含量与SAP组比较明显下降(P<0.05)。结论 PPAR-γ激动剂能减轻急性胰腺炎大鼠肺组织的损伤,抑制NF-κB、TLR4表达,降低促炎细胞因子水平,推测PPAR-γ激动剂对NF-κB/TLR4通路的调节可能是胰腺炎的保护机制之一。Objective To find the protection of PPAR-γ agonists on injured lung cells in rats and mechanism during acute pancreatitis. Methods Rats were divided randomly into three groups: sham operation group, SAP model group, rosiglitazone group. Each group was divided into 6 h, 12 h, and 24 h group after operation. SAP rats model were made via twice peritoneal injection of L-arginine. Rats in ROSI group were injected with 6 mg/kg of 10% rosiglitazone via femoral vein 30 min after operation. Sham operation group rats were peritoneally injected of same volume NS as SAP group. Pathological changes of lung tissue, TLR4, NF-κB, MPO, dry and wet ratio in lung tissue were tested. Serum TNF-α, interieukin-1β, interieukin-6 were also determined. Results The pathological injuries of lung cell were re- lieved in ROSI group compared with SAP group. There were statistic differences in TLR4, NF-κB, MPO, dry and wet ratio in lung between ROS1 and SAP group, which were decreased in ROSI group compared with SAP group(P〈0.05). TNF-α, IL-1β, IL-6 were decreased in ROSI group compared with those in SAP group(P〈0.05). Conclusion The lung tissue injury during SAP may relived by PPAR-γ agonists, and also decrease NF-kappa B, TLR4 and inflammatory cy- tokines. The probable reason is that PPAR-γagonists protect pancreas by adjusting NF-κB/TLR4 signal pathway.

关 键 词:急性胰腺炎 过氧化物酶体增殖物激活受体 核转录因子-ΚB TOLL样受体 

分 类 号:R576[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象